| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |